Northern Trust’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-356,779
| Closed | -$4.67M | – | 4406 |
|
|
2025
Q4 | $4.67M | Buy |
356,779
+3,274
| +0.9% | +$39.1K | ﹤0.01% | 2515 |
|
|
2025
Q3 | $2.57M | Sell |
353,505
-22,472
| -6% | -$152K | ﹤0.01% | 2888 |
|
|
2025
Q2 | $2.02M | Sell |
375,977
-90,606
| -19% | -$439K | ﹤0.01% | 2983 |
|
|
2025
Q1 | $2.49M | Buy |
466,583
+8,349
| +2% | +$58.4K | ﹤0.01% | 2800 |
|
|
2024
Q4 | $4.1M | Buy |
458,234
+19,893
| +5% | +$211K | ﹤0.01% | 2622 |
|
|
2024
Q3 | $4.83M | Buy |
438,341
+22,081
| +5% | +$246K | ﹤0.01% | 2495 |
|
|
2024
Q2 | $3.79M | Sell |
416,260
-13,633
| -3% | -$133K | ﹤0.01% | 2542 |
|
|
2024
Q1 | $6.05M | Buy |
429,893
+126,791
| +42% | +$1.58M | ﹤0.01% | 2349 |
|
|
2023
Q4 | $2.33M | Buy |
303,102
+58,751
| +24% | +$325K | ﹤0.01% | 2906 |
|
|
2023
Q3 | $1.82M | Buy |
244,351
+116
| +0% | +$989 | ﹤0.01% | 2989 |
|
|
2023
Q2 | $2.03M | Buy |
244,235
+196,712
| +414% | +$2.27M | ﹤0.01% | 2996 |
|
|
2023
Q1 | $632K | Buy |
47,523
+21,084
| +80% | +$285K | ﹤0.01% | 3366 |
|
|
2022
Q4 | $394K | Buy |
26,439
+6,846
| +35% | +$70.6K | ﹤0.01% | 3580 |
|
|
2022
Q3 | $177K | Sell |
19,593
-316
| -2% | -$2.12K | ﹤0.01% | 3927 |
|
|
2022
Q2 | $60K | Sell |
19,909
-190
| -0.9% | -$852 | ﹤0.01% | 4347 |
|
|
2022
Q1 | $135K | Sell |
20,099
-1,914
| -9% | -$11.4K | ﹤0.01% | 4257 |
|
|
2021
Q4 | $119K | Buy |
22,013
+2,760
| +14% | +$18.2K | ﹤0.01% | 4372 |
|
|
2021
Q3 | $170K | Buy |
19,253
+5,193
| +37% | +$49.8K | ﹤0.01% | 4244 |
|
|
2021
Q2 | $178K | Sell |
14,060
-28,897
| -67% | -$375K | ﹤0.01% | 4200 |
|
|
2021
Q1 | $745K | Sell |
42,957
-5,518
| -11% | -$99.7K | ﹤0.01% | 3694 |
|
|
2020
Q4 | $623K | Sell |
48,475
-429
| -0.9% | -$7.65K | ﹤0.01% | 3662 |
|
|
2020
Q3 | $1.82M | Buy |
48,904
+23,139
| +90% | +$917K | ﹤0.01% | 3111 |
|
|
2020
Q2 | $994K | Buy |
25,765
+12,868
| +100% | +$458K | ﹤0.01% | 3360 |
|
|
2020
Q1 | $321K | Buy |
12,897
+856
| +7% | +$26.5K | ﹤0.01% | 3558 |
|
|
2019
Q4 | $427K | Buy |
12,041
+2,348
| +24% | +$74K | ﹤0.01% | 3594 |
|
|
2019
Q3 | $314K | Buy |
9,693
+1,327
| +16% | +$52.5K | ﹤0.01% | 3651 |
|
|
2019
Q2 | $405K | Buy |
8,366
+3,577
| +75% | +$162K | ﹤0.01% | 3612 |
|
|
2019
Q1 | $228K | Buy |
4,789
+1,998
| +72% | +$67.7K | ﹤0.01% | 3743 |
|
|
2018
Q4 | $73K | Hold |
2,791
| – | – | ﹤0.01% | 3982 |
|
|
2018
Q3 | $134K | Buy |
2,791
+2,423
| +658% | +$109K | ﹤0.01% | 3965 |
|
|
2018
Q2 | $21K | Hold |
368
| – | – | ﹤0.01% | 4210 |
|
|
2018
Q1 | $40K | Buy |
368
+119
| +48% | +$11.9K | ﹤0.01% | 4105 |
|
|
2017
Q4 | $22K | Buy |
249
+39
| +19% | +$4.59K | ﹤0.01% | 4150 |
|
|
2017
Q3 | $27K | Hold |
210
| – | – | ﹤0.01% | 4126 |
|
|
2017
Q2 | $18K | Hold |
210
| – | – | ﹤0.01% | 4185 |
|
|
2017
Q1 | $20K | Buy |
+210
| New | +$28.9K | ﹤0.01% | 4152 |
|
|
2016
Q2 | – | Sell |
-696
| Closed | -$211K | – | 4229 |
|
|
2016
Q1 | $211K | Buy |
696
+51
| +8% | +$17.6K | ﹤0.01% | 3712 |
|
|
2015
Q4 | $307K | Buy |
+645
| New | +$310K | ﹤0.01% | 3627 |
|
Northern Trust's ATXS Position: Q1 2026 in Review
Northern Trust sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 356,779 shares — an estimated $4.67M sold.
Northern Trust first reported a position in ATXS in Q4 2015 and held it in 38 quarters. The position peaked at $6.05M in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Northern Trust reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 356,779 Astria Therapeutics shares in Q1 2026, an estimated $4.67M.
- Northern Trust first reported a position in Astria Therapeutics in Q4 2015 and held it in 38 quarters.
- Northern Trust's Astria Therapeutics position peaked at $6.05M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.